Gilead Sciences
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Gilead Sciences's balance sheet done over the years? Its assets were worth $62,125,000,000 last year, which is less than in the previous period. 63% of Gilead Sciences’s total assets is currently financed by debt. Its liabilities reached the amount of $39,376,000,000, which means an decrease by -6% compared compared to last year.
Debt to Assets
| 2014 | 34664000000 | 18.84B | 54.36% |
|---|---|---|---|
| 2015 | 51839000000 | 32.72B | 63.13% |
| 2016 | 56977000000 | 37.61B | 66.02% |
| 2017 | 70283000000 | 49.78B | 70.83% |
| 2018 | 63675000000 | 42.14B | 66.18% |
| 2019 | 61627000000 | 38.97B | 63.25% |
| 2020 | 68407000000 | 50.18B | 73.36% |
| 2021 | 67952000000 | 46.88B | 69% |
| 2022 | 63171000000 | 41.96B | 66.43% |
| 2023 | 62125000000 | 39.37B | 63.38% |
GILD Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 6.08B | 5.41B | 5.33B | 5.99B | 11.63B | 17.94B | 7.58B | 8.22B | 12.85B | 10.02B |
Short term investments | 1.17B | 973M | 1.18B | 1.41B | 12.72B | 12.14B | 17.92B | 3.66B | 1.75B | 101M |
Net receivables | 4.66B | 4.77B | 4.49B | 4.89B | 3.58B | 3.32B | 3.85B | 4.51B | 5.85B | 4.63B |
Inventory | 1.78B | 2.82B | 2.73B | 3.01B | 2.06B | 814M | 801M | 1.58B | 1.95B | 1.38B |
Other current assets | 2.37B | 1.77B | 2.14B | 2.01B | 1.44B | 1.60B | 3.32B | 1.06B | 2.34B | 1.56B |
Total current assets | 16.08B | 15.22B | 15.05B | 15.81B | 31.48B | 35.65B | 41.34B | 38.48B | 34.01B | 17.74B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 5.31B | 5.47B | 5.12B | 4.96B | 4.50B | 4.00B | 3.29B | 2.86B | 2.27B | 1.67B |
Goodwill | 8.31B | 8.31B | 8.33B | 8.10B | 4.11B | 4.11B | 4.15B | 1.17B | 1.17B | 1.17B |
Intangible assets | 26.45B | 28.89B | 33.45B | 33.12B | 13.78B | 15.73B | 17.1B | 8.97B | 10.24B | 11.07B |
Long term investments | 1.16B | 1.24B | 1.30B | 502M | 1.48B | 1.42B | 11.18B | 20.48B | 11.60B | 1.59B |
Other non-current assets | 4.79B | 4.01B | 5.98B | 6.39B | 7.73B | 4.16B | 4.38B | -15.39B | -7.79B | 1.16B |
Total non-current assets | 46.04B | 47.94B | 52.89B | 52.59B | 30.13B | 28.02B | 28.93B | 18.49B | 17.82B | 16.91B |
Total assets | 62.12B | 63.17B | 67.95B | 68.40B | 61.62B | 63.67B | 70.28B | 56.97B | 51.83B | 34.66B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 0 | -3.56B | 202M | 440M | 134M |
Short term debt | 1.79B | 2.27B | 1.51B | 2.75B | 2.49B | 2.74B | 2.74B | -1.40B | 982M | 483M |
Total current liabilities | 11.28B | 11.23B | 11.61B | 11.39B | 9.75B | 10.60B | 11.63B | 9.21B | 9.89B | 5.61B |
| Non-current liabilities: | ||||||||||
Long term debt | 23.18B | 22.95B | 25.17B | 28.64B | 22.09B | 24.57B | 30.79B | 26.34B | 21.07B | 11.92B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 3.31B | 5.09B | 976M | 10.14B | 7.12B | 6.96B | 7.35B | 28.39B | 1.76B | 1.11B |
Total non-current liabilities | 28.09B | 30.72B | 35.27B | 38.78B | 29.21B | 31.53B | 38.14B | 28.39B | 22.83B | 13.22B |
Total liabilities | 39.37B | 41.96B | 46.88B | 50.18B | 38.97B | 42.14B | 49.78B | 37.61B | 32.72B | 18.84B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |